Clinical Trial Update: Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, immunogenicity, and efficacy of a therapeutic Mycobacterium bovis BCG (BOOST) for nontuberculous mycobacterial infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection
• Nontuberculous Mycobacterial Infection

Drugs mentioned

• BCG BOOST (Mycobacterium bovis BCG)

Snippet

Sponsor: University of Virginia | Conditions: Mycobacterium Avium-intracellulare Infection, Mycobacterium Infections, Nontuberculous | Phase 2 | Status: NOT_YET_RECRUITING